Company & Sponsor Intelligence

University of British Columbia

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials6
Recruiting1
Completed3
Countries1

Therapeutic footprint

adhddepressionparkinsonsstroke

Indexed studies

NCT06915987Parkinson Disease and Exercise Snacks
parkinsons · Canada
NA
NCT00434928Dietary Intake and Nutrient Status of Children With ADHD
adhd · Canada
COMPLETED
NCT02167048Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD
adhd · Canada
PHASE1, PHASE2
NCT06573125A Feasibility and Preliminary Efficacy Study of an App-Based Physical Activity Intervention (MoodMover) for Depression
depression ·
NA
NCT02654951Reaching in Stroke
stroke · Canada
NA
NCT01915368Determining Optimal Post-Stroke Exercise (DOSE)
stroke · Canada
NA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →